Mengwen Xue

Mengwen Xue

Auto-generated profile, based on publicly available information

Mengwen Xue

Department of Anesthesiology, The First Affiliated Hospital, Xi'an Jiaotong University, Xi'an 710061, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2020 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MXMengwen Xue
Mengwen Xue
LHliang han
liang han
WQWeikun Qian
Weikun Qian
JLJie Li
Jie Li
TQTao Qin
Tao Qin
XSXin Shen
Xin Shen
Pain is the most important clinical feature of acute pancreatitis (AP); however, its specific mechanism is currently unclear. In this study, we showed that AP caused an increase in nitric oxide (NO) secretion, activated the NF-κB pathway in the dorsal root ganglia (DRGs), and caused pain. We established an AP model in vivo and tested the expression of NO, the kappa opioid receptor (KOR), and pain factors. We showed that NO in AP was significantly elevated and increased the expression of pain factors. Next, by treating DRGs in vitro, it was found that NO activated the NF-κB pathway; conversely, NF-κB had no effect on NO. Moreover, inhibition of NF-κB promoted the KOR, whereas NF-κB did not change after KOR activation. Finally, behavioral experiments showed that a NO donor increased the pain behavior of mice, while a NO scavenger, NF-κB inhibitor, or KOR agonist attenuated the pain response in mice. These results suggest that iNOS/NO/NF-κB/KOR may be a key mechanism of pain in AP, providing a theoretical basis for the use of peripheral-restricted KOR agonists for pain treatment in AP.